Heinz Schwer, based in Heidelberg, Baden-Württemberg, Germany, is currently a Managing Director/ Chief Business Officer at VERAXA Biotech GmbH, bringing experience from previous roles at EMBL Ventures, No Company, ViraTherapeutics and Lanthio Pharma. Heinz Schwer holds a 1999 - 2001 Postdoc @ Harvard Medical School. With a robust skill set that includes DNA, Corporate Venture Capital, Strategic Planning, Pharmaceutical Industry, Due Diligence and more, Heinz Schwer contributes valuable insights to the industry. Heinz Schwer has 4 emails and 1 mobile phone number on RocketReach.